Johnson & Johnson FDA Clears OTTAVA Robotic Surgical System
NEW BRUNSWICK, N.J., July 22, 2026 Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW BRUNSWICK, N.J., July 22, 2026 Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has...
SANTA CLARA, Calif., United States – May 5, 2026 Johnson & Johnson has announced pivotal clinical study results for...
